Detalles de la búsqueda
1.
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.
J Pharmacol Exp Ther
; 374(3): 404-419, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32605972
2.
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
Neuropharmacology
; 38(3): 331-8, 1999 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10219971
3.
On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regression.
J Med Chem
; 38(16): 3121-31, 1995 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-7636874
4.
Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity.
J Med Chem
; 38(8): 1319-29, 1995 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-7731017
5.
Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.
J Med Chem
; 37(17): 2735-53, 1994 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-8064801
6.
Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonists.
J Med Chem
; 36(21): 3188-96, 1993 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8230107
7.
Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
J Med Chem
; 36(22): 3409-16, 1993 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-8230131
8.
Effects of the dopamine autoreceptor antagonist (-)-DS121 on the discriminative stimulus properties of d-amphetamine and cocaine.
Eur J Pharmacol
; 275(1): 67-74, 1995 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-7774664
9.
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions.
Eur J Pharmacol
; 389(2-3): 193-9, 2000 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-10688984
10.
Potential anxiolytic properties of R-(+)-8-OSO2CF3-PAT, a 5-HT 1A receptor agonist.
Eur J Pharmacol
; 297(3): 205-11, 1996 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-8666051
11.
Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography.
Nucl Med Biol
; 24(6): 507-11, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9316077
12.
Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease.
Neurology
; 53(7): 1605-6, 1999 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-10534281
13.
A recycling framework for the construction of Bonferroni-based multiple tests.
Stat Med
; 28(5): 739-61, 2009 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-19142850
14.
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour.
J Neural Transm Gen Sect
; 98(1): 39-55, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7710738
15.
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity.
Synapse
; 28(4): 280-7, 1998 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-9517836
Resultados
1 -
15
de 15
1
Próxima >
>>